These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28789823)

  • 41. A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection.
    Coutance G; Desiré E; Duong Van Huyen JP
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
    Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
    Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial.
    Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H
    J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum biomarkers of acute rejection: Towards precision medicine in heart transplant.
    Ortiz-Bautista C; Fernández-Avilés F; Delgado Jiménez JF
    J Heart Lung Transplant; 2021 Oct; 40(10):1090-1097. PubMed ID: 34330605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The exosome as a novel predictive/diagnostic biomarker of rejection in the field of transplantation.
    Mirzakhani M; Mohammadnia-Afrouzi M; Shahbazi M; Mirhosseini SA; Hosseini HM; Amani J
    Clin Immunol; 2019 Jun; 203():134-141. PubMed ID: 31077803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection.
    Zhang H; Huang E; Kahwaji J; Nast CC; Li P; Mirocha J; Thomas DL; Ge S; Vo AA; Jordan SC; Toyoda M
    Transplantation; 2017 Oct; 101(10):2419-2428. PubMed ID: 28557957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor myocardial apollon mRNA is associated with cardiac allograft rejection.
    Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Aliabadi A; Zuckermann A; Grimm M
    J Heart Lung Transplant; 2010 Jul; 29(7):777-85. PubMed ID: 20462770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue-associated self-antigens containing exosomes: Role in allograft rejection.
    Sharma M; Ravichandran R; Bansal S; Bremner RM; Smith MA; Mohanakumar T
    Hum Immunol; 2018 Sep; 79(9):653-658. PubMed ID: 29908844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
    Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
    Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-Effectiveness of Highly Sensitive Cardiac Troponin T to Rule Out Acute Rejection After Heart Transplantation.
    Méndez AB; Ordonez-Llanos J; Farrero M; Mirabet S; Brossa V; López L; Bonet R; Sionis A; Pérez-Villa F; Roig E
    Transplant Proc; 2015 Oct; 47(8):2395-6. PubMed ID: 26518938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review.
    Fitzsimons S; Evans J; Parameshwar J; Pettit SJ
    J Heart Lung Transplant; 2018 May; 37(5):631-638. PubMed ID: 29426716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathologic diagnosis of antibody-mediated rejection in endomyocardial biopsy after heart transplantation based on renewed International Society for Heart and Lung Transplantation criteria.
    Szymańska S; Grajkowska W; Pronicki M
    Pol J Pathol; 2014 Oct; 65(3):176-81. PubMed ID: 25372414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computerized heart allograft-recipient monitoring: a multicenter study.
    Grasser B; Iberer F; Schreier G; Kastner P; Schaffellner S; Kniepeiss D; Kleinert R; Mahaux V; Demoulin JC; Nägele H; Rödiger W; Laufer G; Grimm M; Zuckermann A; Wasler A; Prenner G; Tscheliessnigg KH;
    Transpl Int; 2003 Apr; 16(4):225-30. PubMed ID: 12730802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.
    Battes LC; Caliskan K; Rizopoulos D; Constantinescu AA; Robertus JL; Akkerhuis M; Manintveld OC; Boersma E; Kardys I
    Transplantation; 2015 Mar; 99(3):580-5. PubMed ID: 25136844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis.
    Heidari SS; Nafar M; Kalantari S; Tavilani H; Karimi J; Foster L; Moon KM; Khodadadi I
    J Proteomics; 2021 May; 240():104208. PubMed ID: 33785428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: A cross-sectional study.
    Lim JH; Lee CH; Kim KY; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Baek MC; Park JB; Kim YH; Chung BH; Lee SH; Kim CD
    PLoS One; 2018; 13(9):e0204204. PubMed ID: 30226858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating growth differentiation factor-15 as a novel biomarker in heart transplant.
    Tokavanich N; Sinphurmsukskul S; Kongruttanachok N; Thammanatsakul K; Sritangsirikul S; Ariyachaipanich A; Ongcharit P; Siwamogsatham S; Boonyaratavej S; Puwanant S
    ESC Heart Fail; 2021 Aug; 8(4):3279-3285. PubMed ID: 34110100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.
    Ware AL; Malmberg E; Delgado JC; Hammond ME; Miller DV; Stehlik J; Kfoury A; Revelo MP; Eckhauser A; Everitt MD
    J Heart Lung Transplant; 2016 Feb; 35(2):179-85. PubMed ID: 26520246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.